Document Detail


Safety and toxicity of oxamniquine in the treatment of Schistosoma mansoni infections, with particular reference to electroencephalographic abnormalities.
MedLine Citation:
PMID:  6650735     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Thirty-seven patients infected with Schistosoma mansoni were treated with oxamniquine. All were cured. The only significant adverse reaction was the development of abnormal electroencephalographic (EEG) findings in 6 (17.6%) of 34 patients whose pretreatment EEG was normal. Management of patients, with particular reference to the EEG abnormalities, is discussed.
Authors:
S Krajden; J S Keystone; C Glenn
Related Documents :
11786735 - Tc-99m ethylcysteinate dimer brain spect perfusion imaging in ictal nonepileptic visual...
11133305 - Localization of interictal delta and epileptiform eeg activity associated with focal ep...
22037385 - Pharmacokinetics and pharmacodynamics of meropenem in elderly chinese with lower respir...
1159445 - Evaluation and outcome of aphasia in patients with severe closed head trauma.
15602865 - Anosmia following superior turbinate resection.
8923365 - Increased pigmentation in scleroderma.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The American journal of tropical medicine and hygiene     Volume:  32     ISSN:  0002-9637     ISO Abbreviation:  Am. J. Trop. Med. Hyg.     Publication Date:  1983 Nov 
Date Detail:
Created Date:  1984-01-26     Completed Date:  1984-01-26     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0370507     Medline TA:  Am J Trop Med Hyg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1344-6     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Child
Drug Evaluation
Electroencephalography*
Female
Humans
Male
Middle Aged
Nitroquinolines / adverse effects*
Oxamniquine / adverse effects*
Schistosoma mansoni
Schistosomiasis / drug therapy*
Chemical
Reg. No./Substance:
0/Nitroquinolines; 21738-42-1/Oxamniquine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Relationship of prevalence and intensity of infection to morbidity in schistosomiasis japonica: a st...
Next Document:  Amoscanate as a topically applied chemical for prophylaxis against Schistosoma mansoni infections in...